GlassScriptPhysician profile
Araceli Gonzalez
NPI 1861086480
$4,612.84
in general payments reported to CMS, 2019-2025
35 companies · $1,079 in 2025
The $1,079 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $576 · 2022: $1,086 · 2023: $955 · 2024: $918 · 2025: $1,079.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,951.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $953.70 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $872.58 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Abbvie INC. | $475.32 | 2021-2025 | |
| Pfizer INC. | $319.03 | 2023-2025 | |
| Lilly USA, LLC | $315.93 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Merck Sharp & Dohme LLC | $211.51 | 2021-2025 | Gardasil 9, Capvaxive, Vaxelis |
| Dexcom, INC. | $187.53 | 2023-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $137.61 | 2023-2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $131.07 | 2022-2025 | |
| Horizon Therapeutics Plc | $114.33 | 2021 | |
| Nestle Healthcare Nutrition INC. | $107.59 | 2022-2023 | |
| Astellas Pharma US INC | $70.78 | 2024 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.14 | 2024-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $62.15 | 2024-2025 | Spravato |
| Xeris Pharmaceuticals, INC. | $53.72 | 2024-2025 | Gvoke Hypopen |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $43.59 | 2025 | Shingrix |
| Novartis Pharmaceuticals Corporation | $38.64 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $37.09 | 2022 | |
| Aimmune Therapeutics, INC. | $36.84 | 2024-2025 | Zenpep |
| Amphastar Pharmaceuticals, INC. | $36.68 | 2024-2025 | Baqsimi |
| Enterra Medical, INC. | $36.27 | 2023 | |
| Abbott Laboratories | $35.78 | 2025 | Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $30.03 | 2021-2022 | |
| Ultragenyx Pharmaceutical INC. | $24.14 | 2022 | |
| Boston Scientific Corporation | $22.98 | 2021 | |
| Lundbeck LLC | $22.94 | 2023 | Rexulti |
| Ardelyx, INC. | $21.85 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.45 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $19.86 | 2023 | Jynarque |
| Daiichi Sankyo INC. | $19.19 | 2021 | |
| Bausch Health US, LLC | $18.39 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.88 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $16.96 | 2024 | |
| Paratek Pharmaceuticals, INC. | $15.74 | 2024 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $15.55 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Araceli Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.